Evidence map›Paper›PMID 33818861›Full record

ReviewCell biology international2021

The role of autophagy in controlling SARS-CoV-2 infection: An overview on virophagy-mediated molecular drug targets.

Saman Sargazi, Roghayeh Sheervalilou, Mohsen Rokni, Milad Shirvaliloo, Omolbanin Shahraki, Nima Rezaei

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell biology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Post-Acute Sequelae and Mitochondrial Aberration in SARS-CoV-2 Infection.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Autophagy in Inflammatory Response against SARS-CoV-2.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. The Impact ofDiabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Saman SargaziCellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
Roghayeh SheervalilouPharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.ORCID http://orcid.org/0000-0001-7996-845X
Mohsen RokniDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Milad ShirvalilooStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0001-5122-1274
Omolbanin ShahrakiPharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Nima RezaeiDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-3836-1827
Zahedan University of Medical Sciences · IRUniversal Scientific Education and Research Network · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy-dependent cell death is a prominent mechanism that majorly contributes to homeostasis by maintaining the turnover of organelles under stressful conditions. Several viruses, including coronaviruses (CoVs), take advantage of cellular autophagy to facilitate their own replication. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta-coronavirus (β-CoVs) that mediates its replication through a dependent or independent ATG5 pathway using specific double-membrane vesicles that can be considered as similar to autophagosomes. With due attention to several mutations in NSP6, a nonstructural protein with a positive regulatory effect on autophagosome formation, a potential correlation between SARS-CoV-2 pathogenesis mechanisms and autophagy can be expected. Certain medications, albeit limited in number, have been indicated to negatively regulate autophagy flux, potentially in a way similar to the inhibitory effect of β-CoVs on the process of autophagy. However, there is no conclusive evidence to support their direct antagonizing effect on CoVs. Off-target accumulation of a major fraction of FDA-approved autophagy modulating drugs may result in adverse effects. Therefore, medications that have modulatory effects on autophagy could be considered as potential lead compounds for the development of new treatments against this virus. This review discusses the role of autophagy/virophagy in controlling SARS-CoV-2, focusing on the potential therapeutic implications.

Indexed as

AutophagyCOVID-19Drug Delivery SystemsHumansSARS-CoV-2autophagybeta-coronaviruscoronavirus disease 2019severe acute respiratory syndrome coronavirus 2virophagy

Identifiers

PMID33818861
PMCPMC8251464
OpenAlexW3152196988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.